Review Article | Published:

Relapse to opioid seeking in rat models: behavior, pharmacology and circuits

Neuropsychopharmacologyvolume 44pages465477 (2019) | Download Citation

Subjects

Abstract

Lifetime relapse rates remain a major obstacle in addressing the current opioid crisis. Relapse to opioid use can be modeled in rodent studies where drug self-administration is followed by a period of abstinence and a subsequent test for drug seeking. Abstinence can be achieved through extinction training, forced abstinence, or voluntary abstinence. Voluntary abstinence can be accomplished by introducing adverse consequences of continued drug self-administration (e.g., punishment or electric barrier) or by introducing an alternative nondrug reward in a discrete choice procedure (drug versus palatable food or social interaction). In this review, we first discuss pharmacological and circuit mechanisms of opioid seeking, as assessed in the classical extinction-reinstatement model, where reinstatement is induced by reexposure to the self-administered drug (drug priming), discrete cues, discriminative cues, drug-associated contexts, different forms of stress, or withdrawal states. Next, we discuss pharmacological and circuit mechanisms of relapse after forced or voluntary abstinence, including the phenomenon of “incubation of heroin craving” (the time-dependent increases in heroin seeking during abstinence). We conclude by discussing future directions of preclinical relapse-related studies using opioid drugs.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Hunt WA, Barnett LW, Branch LG. Relapse rates in addiction programs. J Clin Psychol. 1971;27:455–6.

  2. 2.

    Sinha R. New findings on biological factors predicting addiction relapse vulnerability. Curr Psychiatry Rep. 2011;13:398–405.

  3. 3.

    Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016. MMWR Morb Mortal Wkly Rep. 2018;67:349–358.

  4. 4.

    Shaham Y, Shalev U, Lu L, de Wit H, Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology. 2003;168:3–20.

  5. 5.

    Stewart J, de Wit H. Reinstatement of drug-taking behavior as a method of assessing incentive motivational properties of drugs. In: Bozarth MA, ed. Methods of assessing the reinforcing properties of abused drugs.. New York, NY: Springer-Verlag; 1987. p. 211–27.

  6. 6.

    Venniro M, Caprioli D, Shaham Y. Animal models of drug relapse and craving: From drug priming-induced reinstatement to incubation of craving after voluntary abstinence. Prog Brain Res. 2016;224:25–52.

  7. 7.

    Cooper A, Barnea-Ygael N, Levy D, Shaham Y, Zangen A. A Conflict Rat Model of Cue-Induced Relapse to Cocaine Seeking. Psychopharmacology. 2007;194:117–25.

  8. 8.

    Panlilio LV, Thorndike EB, Schindler CW. Reinstatement of punishment-suppressed opioid self-administration in rats: an alternative model of relapse to drug abuse. Psychopharmacology. 2003;168:229–35.

  9. 9.

    Caprioli D, Venniro M, Zeric T, Li X, Adhikary S, Madangopal R, et al. Effect of the novel positive allosteric modulator of metabotropic glutamate receptor 2 AZD8529 on incubation of methamphetamine craving after prolonged voluntary abstinence in a rat model. Biol Psychiatry. 2015;78:463–73.

  10. 10.

    Venniro M, Zhang M, Caprioli D, Golden SA, Heins C, Hoots JK, et al. (2018): Volitional social interaction prevents drug addiction. Nat Neurosci. (in press).

  11. 11.

    de Wit H, Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology. 1981;75:134–43.

  12. 12.

    Meil WM, See RE. Conditioned cued recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse. Behav Pharmacol. 1996;7:754–63.

  13. 13.

    Crombag HS, Shaham Y. Renewal of drug seeking by contextual cues after prolonged extinction in rats. Behav Neurosci. 2002;116:169–73.

  14. 14.

    Katner SN, Magalong JG, Weiss F. Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat. Neuropsychopharmacology. 1999;20:471–9.

  15. 15.

    Shaham Y, Stewart J. Stress reinstates heroin self-administration behavior in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology. 1995;119:334–41.

  16. 16.

    Shaham Y, Rajabi H, Stewart J. Relapse to heroin-seeking in rats under opioid maintenance: the effects of stress, heroin priming, and withdrawal. J Neurosci. 1996;16:1957–63.

  17. 17.

    de Wit H. Priming effects with drugs and other reinforcers. Exp Clin Psychopharmacol. 1996;4:5–10.

  18. 18.

    Sinha R, Shaham Y, Heilig M. Translational and reverse translational research on the role of stress in drug craving and relapse. Psychopharmacology. 2011;218:69–82.

  19. 19.

    Jaffe JH, Cascella NG, Kumor KM, Sherer MA. Cocaine-induced cocaine craving. Psychopharmacology. 1989;97:59–64.

  20. 20.

    O’Brien CP, Childress AR, Mclellan TA, Ehrman R. Classical conditioning in drug dependent humans. Ann NY Acad Sci. 1992;654:400–15.

  21. 21.

    Wikler A. Dynamics of drug dependence. Implications of a conditioning theory for research and treatment. Arch Gen Psychiatry. 1973;28:611–6.

  22. 22.

    Marchant NJ, Li X, Shaham Y. Recent developments in animal models of drug relapse. Curr Opin Neurobiol. 2013;23:675–83.

  23. 23.

    Epstein DH, Preston KL. The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology. 2003;168:31–41.

  24. 24.

    Katz JL, Higgins ST. The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology. 2003;168:21–30.

  25. 25.

    Marlatt AG. Models of relapse and relapse prevention: a commentary. Exp Clin Psychopharmacol. 1996;4:55–60.

  26. 26.

    de Wit H, Epstein DH, Preston KL. Does human language limit translatability of clinical and preclinical addiction research? Neuropsychopharmacology. 2018;43:1985–8.

  27. 27.

    Shaham Y, Stewart J. Effects of opioid and dopamine receptor antagonists on relapse induced by stress and reexposure to heroin in rats. Psychopharmacology. 1996;125:385–91.

  28. 28.

    De Vries TJ, Homberg JR, Binnekade R, Raaso H, Schoffelmeer AN. Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology. 2003;168:164–9.

  29. 29.

    De Vries TJ, Schoffelmeer AN, Binnekade R, Raaso H, Vanderschuren LJ. Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization. Neuropsychopharmacology. 2002;26:18–26.

  30. 30.

    Wise RA, Murray A, Bozarth MA. Bromocriptine self-administration and bromocriptine- reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology. 1990;100:355–60.

  31. 31.

    Fattore L, Spano MS, Cossu G, Deiana S, Fratta W. Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats. Eur J Neurosci. 2003;17:1723–6.

  32. 32.

    Fattore L, Spano S, Cossu G, Deiana S, Fadda P, Fratta W. Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats. Neuropharmacology. 2005;48:1097–104.

  33. 33.

    You ZB, Gao JT, Bi GH, He Y, Boateng C, Cao J, et al. The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats. Neuropharmacology. 2017;126:190–9.

  34. 34.

    Stewart J. Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol Biochem Behav. 1984;20:917–23.

  35. 35.

    Wise RA. Opiate reward: sites and substrates. Neurosci Biobehav Rev. 1989;13:129–33.

  36. 36.

    Stewart J, Vezina P. A comparison of the effects of intra-accumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior. Brain Res. 1988;457:287–94.

  37. 37.

    LaLumiere RT, Kalivas PW. Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci. 2008;28:3170–7.

  38. 38.

    Shen H, Moussawi K, Zhou W, Toda S, Kalivas PW. Heroin relapse requires long-term potentiation-like plasticity mediated by NMDA2b-containing receptors. Proc Natl Acad Sci USA. 2011;108:19407–412.

  39. 39.

    Fuchs RA, See RE. Basolateral amygdala inactivation abolishes conditioned stimulus- and heroin-induced reinstatement of extinguished heroin-seeking behavior in rats. Psychopharmacology. 2002;160:425–33.

  40. 40.

    Rogers JL, Ghee S, See RE. The neural circuitry underlying reinstatement of heroin-seeking behavior in an animal model of relapse. Neuroscience. 2008;151:579–88.

  41. 41.

    Lai M, Chen W, Zhu H, Zhou X, Liu H, Zhang F, et al. Low dose risperidone attenuates cue-induced but not heroin-induced reinstatement of heroin seeking in an animal model of relapse. Int J Neuropsychopharmacol. 2013;16:1569–75.

  42. 42.

    Yue K, Ma B, Chen L, Tian X, Ru Q, Gan Y, et al. L-Stepholidine, a naturally occurring dopamine D1 receptor agonist and D2 receptor antagonist, attenuates heroin self-administration and cue-induced reinstatement in rats. Neuroreport 2014;25:7–11.

  43. 43.

    Galaj E, Manuszak M, Babic S, Ananthan S, Ranaldi R. The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats. Drug Alcohol Depend. 2015;156:228–33.

  44. 44.

    Porter-Stransky KA, Bentzley BS, Aston-Jones G. Individual differences in orexin-I receptor modulation of motivation for the opioid remifentanil. Addict Biol. 2017;22:303–17.

  45. 45.

    Smith RJ, Aston-Jones G. Orexin/hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking. Eur J Neurosci. 2012;35:798–804.

  46. 46.

    Schmidt ED, Voorn P, Binnekade R, Schoffelmeer AN, De Vries TJ. Differential involvement of the prelimbic cortex and striatum in conditioned heroin and sucrose seeking following long-term extinction. Eur J Neurosci. 2005;22:2347–56.

  47. 47.

    Koya E, Spijker S, Voorn P, Binnekade R, Schmidt ED, Schoffelmeer AN, et al. Enhanced cortical and accumbal molecular reactivity associated with conditioned heroin, but not sucrose-seeking behaviour. J Neurochem. 2006;98:905–15.

  48. 48.

    Zhou W, Liu H, Zhang F, Tang S, Zhu H, Lai M, et al. Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin-seeking induced by conditioned cues. Neuroscience. 2007;144:1209–18.

  49. 49.

    Bossert JM, Poles GC, Wihbey KA, Koya E, Shaham Y. Differential effects of blockade of dopamine D1-family receptors in nucleus accumbens core or shell on reinstatement of heroin seeking induced by contextual and discrete cues. J Neurosci. 2007;27:12655–63.

  50. 50.

    Shen HW, Scofield MD, Boger H, Hensley M, Kalivas PW. Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse. J Neurosci. 2014;34:5649–57.

  51. 51.

    See RE. Dopamine D1 receptor antagonism in the prelimbic cortex blocks the reinstatement of heroin-seeking in an animal model of relapse. Int J Neuropsychopharmacol. 2009;12:431–46.

  52. 52.

    Chen W, Wang Y, Sun A, Zhou L, Xu W, Zhu H, et al. Activation of AMPA receptor in the infralimbic cortex facilitates extinction and attenuates the heroin-seeking behavior in rats. Neurosci Lett. 2016;612:126–31.

  53. 53.

    Van den Oever MC, Goriounova NA, Li KW, Van der Schors RC, Binnekade R, Schoffelmeer AN, et al. Prefrontal cortex AMPA receptor plasticity is crucial for cue-induced relapse to heroin-seeking. Nat Neurosci. 2008;11:1053–8.

  54. 54.

    Van den Oever MC, Lubbers BR, Goriounova NA, Li KW, Van der Schors RC, Loos M, et al. Extracellular matrix plasticity and GABAergic inhibition of prefrontal cortex pyramidal cells facilitates relapse to heroin seeking. Neuropsychopharmacology. 2010;35:2120–33.

  55. 55.

    Smith AC, Kupchik YM, Scofield MD, Gipson CD, Wiggins A, Thomas CA, et al. Synaptic plasticity mediating cocaine relapse requires matrix metalloproteinases. Nat Neurosci. 2014;17:1655–7.

  56. 56.

    Liu H, Lai M, Zhou X, Zhu H, Liu Y, Sun A, et al. Galantamine attenuates the heroin seeking behaviors induced by cues after prolonged withdrawal in rats. Neuropharmacology . 2012;62:2515–21.

  57. 57.

    Weiss F, Maldonado-Vlaar CS, Parsons LH, Kerr TM, Smith DL, Ben-Shahar O. Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proc Natl Acad Sci USA. 2000;97:4321–6.

  58. 58.

    McFarland K, Ettenberg A. Reinstatement of drug-seeking behavior produced by heroin-predictive environmental stimuli. Psychopharmacology. 1997;131:86–92.

  59. 59.

    Gracy KN, Dankiewicz LA, Weiss F, Koob GF. Heroin-specific stimuli reinstate operant heroin-seeking behavior in rats after prolonged extinction. Pharmacol Biochem Behav. 2000;65:489–94.

  60. 60.

    Zhou W, Zhang F, Tang S, Liu H, Gu J, Yang G. The dissociation of heroin-seeking patterns induced by contextual, discriminative, or discrete conditioned cues in a model of relapse to heroin in rats. Psychopharmacology. 2005;181:197–206.

  61. 61.

    Alvarez-Jaimes L, Polis I, Parsons LH. Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB1 antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala. Neuropsychopharmacology. 2008;33:2483–93.

  62. 62.

    Crombag HS, Bossert JM, Koya E, Shaham Y. Review. Context-induced relapse to drug seeking: a review. Philos Trans R Soc Lond B Biol Sci. 2008;363:3233–43.

  63. 63.

    Bossert JM, Hoots JK, Fredriksson I, Adhikary, Zhang M, Venniro M, et al. (2018). Role of mu, but not delta or kappa, opioid receptors in context-induced reinstatement of oxycodone seeking. Eur J Neurosci. (in press).

  64. 64.

    Bossert JM, Liu SY, Lu L, Shaham Y. A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking. J Neurosci. 2004;24:10726–30.

  65. 65.

    Bossert JM, Gray SM, Lu L, Shaham Y. Activation of group II metabotropic glutamate receptors in the nucleus accumbens shell attenuates context-induced relapse to heroin seeking. Neuropsychopharmacology. 2006;31:2197–209.

  66. 66.

    Bossert JM, Wihbey K, Pickens CL, Nair SG, Shaham Y. Role of dopamine D1-family receptors in dorsolateral striatum in context-induced reinstatement of heroin seeking in rats. Psychopharmacology. 2009;206:51–60.

  67. 67.

    Groenewegen HJ, Wright CI, Beijer AV, Voorn P. Convergence and segregation of ventral striatal inputs and outputs. Ann NY Acad Sci. 1999;877:49–63.

  68. 68.

    Bossert JM, Stern AL, Theberge FR, Cifani C, Koya E, Hope BT, et al. Ventral medial prefrontal cortex neuronal ensembles mediate context-induced relapse to heroin. Nat Neurosci. 2011;14:420–2.

  69. 69.

    Gold RM. Aphagia and adipsia produced by unilateral hypothalamic lesions in rats. Am J Physiol. 1966;211:1274–6.

  70. 70.

    Bossert JM, Stern AL, Theberge FR, Marchant NJ, Wang HL, Morales M, et al. Role of projections from ventral medial prefrontal cortex to nucleus accumbens shell in context-induced reinstatement of heroin seeking. J Neurosci. 2012;32:4982–91.

  71. 71.

    Bossert JM, Stern AL. Role of ventral subiculum in context-induced reinstatement of heroin seeking in rats. Addict Biol. 2014;19:338–42.

  72. 72.

    Bossert JM, Adhikary S, St Laurent R, Marchant NJ, Wang HL, Morales M, et al. Role of projections from ventral subiculum to nucleus accumbens shell in context-induced reinstatement of heroin seeking in rats. Psychopharmacology. 2016;233:1991–2004.

  73. 73.

    Jay TM, Witter MP. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin. J Comp Neurol. 1991;313:574–86.

  74. 74.

    Wang N, Ge F, Cui C, Li Y, Sun X, Sun L, et al. Role of glutamatergic projections from the ventral CA1 to infralimbic cortex in context-induced reinstatement of heroin seeking. Neuropsychopharmacology. 2018;43:1373–84.

  75. 75.

    Ge F, Wang N, Cui C, Li Y, Liu Y, Ma Y, et al. Glutamatergic projections from the entorhinal cortex to dorsal dentate gyrus mediate context-induced reinstatement of heroin seeking. Neuropsychopharmacology. 2017;42:1860–70.

  76. 76.

    Mantsch JR, Baker DA, Funk D, Le AD, Shaham Y. Stress-induced reinstatement of drug seeking: 20 years of progress. Neuropsychopharmacology. 2016;41:335–56.

  77. 77.

    Shaham Y, Erb S, Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Brain Res Rev. 2000;33:13–33.

  78. 78.

    Ahmed SH, Walker JR, Koob GF. Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology. 2000;22:413–21.

  79. 79.

    Shalev U, Highfield D, Yap J, Shaham Y. Stress and relapse to drug seeking in rats: studies on the generality of the effect. Psychopharmacology. 2000;150:337–46.

  80. 80.

    Chen YW, Fiscella KA, Bacharach SZ, Tanda G, Shaham Y, Calu DJ. Effect of yohimbine on reinstatement of operant responding in rats is dependent on cue contingency but not food reward history. Addict Biol. 2015;20:690–700.

  81. 81.

    Wang B, You ZB, Wise RA. Heroin self-administration experience establishes control of ventral tegmental glutamate release by stress and environmental stimuli. Neuropsychopharmacology. 2012;37:2863–9.

  82. 82.

    Shaham Y, Highfield D, Delfs J, Leung S, Stewart J. Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci. 2000;12:292–302.

  83. 83.

    Highfield D, Yap J, Grimm JW, Shalev U, Shaham Y. Repeated lofexidine treatment attenuates stress-induced, but not drug cues-induced reinstatement of a heroin–cocaine mixture (speedball) seeking in rats. Neuropsychopharmacology. 2001;25:320–31.

  84. 84.

    Kvetnansky R, Sabban EL, Palkovits M. Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev. 2009;89:535–606.

  85. 85.

    Aston-Jones G, Delfs JM, Druhan J, Zhu Y. The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann NY Acad Sci. 1999;877:486–98.

  86. 86.

    Shaham Y, Funk D, Erb S, Brown TJ, Walker CD, Stewart J. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci. 1997;17:2605–14.

  87. 87.

    Shaham Y, Erb S, Leung S, Buczek Y, Stewart J. CP-154,526, a selective, non peptide antagonist of the corticotropin-releasing factor type 1 receptor attenuates stress-induced relapse to drug seeking in cocaine-and heroin-trained rats. Psychopharmacology. 1998;137:184–90.

  88. 88.

    Highfield D, Clements A, Shalev U, McDonald R, Featherstone R, Stewart J, et al. Involvement of the medial septum in stress-induced relapse to heroin seeking in rats. Eur J Neurosci. 2000;12:1705–13.

  89. 89.

    Shalev U, Yap J, Shaham Y. Leptin attenuates acute food deprivation-induced relapse to heroin seeking. J Neurosci. 2001;21:RC129.

  90. 90.

    Maric T, Tobin S, Quinn T, Shalev U. Food deprivation-like effects of neuropeptide Y on heroin self-administration and reinstatement of heroin seeking in rats. Behav Brain Res. 2008;194:39–43.

  91. 91.

    Maric T, Sedki F, Chafetz D, Schoela N, Shalev U. A role for neuropeptide Y Y5 but not the Y1-receptor subtype in food deprivation-induced reinstatement of heroin seeking in the rat. Psychopharmacology. 2011;218:693–701.

  92. 92.

    Shalev U, Finnie PS, Quinn T, Tobin S, Wahi P. A role for corticotropin-releasing factor, but not corticosterone, in acute food-deprivation-induced reinstatement of heroin seeking in rats. Psychopharmacology. 2006;187:376–84.

  93. 93.

    Sedki F, Eigenmann K, Gelinas J, Schouela N, Courchesne S, Shalev U. A role for kappa-, but not mu-opioid, receptor activation in acute food deprivation-induced reinstatement of heroin seeking in rats. Addict Biol. 2015;20:423–32.

  94. 94.

    Tobin S, Newman AH, Quinn T, Shalev U. A role for dopamine D1-like receptors in acute food deprivation-induced reinstatement of heroin seeking in rats. Int J Neuropsychopharmacol. 2009;12:217–26.

  95. 95.

    Tobin S, Sedki F, Abbas Z, Shalev U. Antagonism of the dopamine D1-like receptor in mesocorticolimbic nuclei attenuates acute food deprivation-induced reinstatement of heroin seeking in rats. Eur J Neurosci. 2013;37:972–81.

  96. 96.

    Shalev U. Chronic food restriction augments the reinstatement of extinguished heroin-seeking behavior in rats. Addict Biol. 2012;17:691–3.

  97. 97.

    Bouton ME, Swartzentruber D. Sources of relapse after extinction in Pavlovian and instrumental learning. Clin Psychol Rev. 1991;11:123–40.

  98. 98.

    D’Cunha TM, Sedki F, Macri J, Casola C, Shalev U. The effects of chronic food restriction on cue-induced heroin seeking in abstinent male rats. Psychopharmacology. 2013;225:241–50.

  99. 99.

    Sedki F, D’Cunha T, Shalev U. A procedure to study the effect of prolonged food restriction on heroin seeking in abstinent rats. J Vis Exp. 2013;81:e50751.

  100. 100.

    D’Cunha TM, Daoud E, Rizzo D, Bishop AB, Russo M, Mourra G, et al. Augmentation of heroin seeking following chronic food restriction in the rat: differential role for dopamine transmission in the nucleus accumbens shell and core. Neuropsychopharmacology. 2017;42:1136–45.

  101. 101.

    Sedki F, Abbas Z, Angelis S, Martin J, D’Cunha T, Shalev U. Is it stress? The role of stress related systems in chronic food restriction-induced augmentation of heroin seeking in the rat. Front Neurosci. 2013;7:1–10.

  102. 102.

    Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. a clinical trial with methadone hydrochloride. J Am Med Assoc. 1965;193:646–50.

  103. 103.

    Stewart J, Wise RA. Reinstatement of heroin self-administration habits: morphine prompts and naltrexone discourages renewed responding after extinction. Psychopharmacology. 1992;108:79–84.

  104. 104.

    Zhou W, Zhang F, Liu H, Tang S, Lai M, Zhu H, et al. Effects of training and withdrawal periods on heroin seeking induced by conditioned cue in an animal of model of relapse. Psychopharmacology. 2009;203:677–84.

  105. 105.

    Li N, He S, Parrish C, Delich J, Grasing K. Differences in morphine and cocaine reinforcement under fixed and progressive ratio schedules; effects of extinction, reacquisition and schedule design. Behav Pharmacol. 2003;14:619–30.

  106. 106.

    Davis WM, Smith SG, Khalsa JH. Noradrenergic role in the self-administration of morphine or amphetamine. Pharmacol Biochem Behav. 1975;3:477–84.

  107. 107.

    Grasing K, He S. Effects of high-dose selegiline on morphine reinforcement and precipitated withdrawal in dependent rats. Behav Pharmacol. 2005;16:1–13.

  108. 108.

    Grasing K, He S, Li N. Selegiline modifies the extinction of responding following morphine self-administration, but does not alter cue-induced reinstatement, reacquisition of morphine reinforcement, or precipitated withdrawal. Pharmacol Res. 2005;51:69–78.

  109. 109.

    Abercrombie EA, Keefe KA, Difrischia DS, Zigmond MJ. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem. 1989;52:1655–8.

  110. 110.

    Minhas M, Leri F. The effect of heroin dependence on resumption of heroin self-administration in rats. Drug Alcohol Depend. 2014;138:24–31.

  111. 111.

    Olmstead MC, Munn EM, Franklin KB, Wise RA. Effects of pedunculopontine tegmental nucleus lesions on responding for intravenous heroin under different schedules of reinforcement. J Neurosci. 1998;18:5035–44.

  112. 112.

    Fuchs RA, Branham RK, See RE. Different neural substrates mediate cocaine seeking after abstinence versus extinction training: a critical role for the dorsolateral caudate-putamen. J Neurosci. 2006;26:3584–8.

  113. 113.

    Dong Y, Taylor JR, Wolf ME, Shaham Y. Circuit and synaptic plasticity mechanisms of drug relapse. J Neurosci. 2017;37:10867–76.

  114. 114.

    Pickens CL, Airavaara M, Theberge F, Fanous S, Hope BT, Shaham Y. Neurobiology of the incubation of drug craving. Trends Neurosci. 2011;34:411–20.

  115. 115.

    Grimm JW, Hope BT, Wise RA, Shaham Y. Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature. 2001;412:141–2.

  116. 116.

    Bedi G, Preston KL, Epstein DH, Heishman SJ, Marrone GF, Shaham Y, et al. Incubation of cue-induced cigarette craving during abstinence in human smokers. Biol Psychiatry. 2011;69:708–11.

  117. 117.

    Wang G, Shi J, Chen N, Xu L, Li J, Li P, et al. Effects of length of abstinence on decision-making and craving in methamphetamine abusers. PLoS One. 2013;8:e68791.

  118. 118.

    Li P, Wu P, Xin X, Fan YL, Wang GB, Wang F, et al. Incubation of alcohol craving during abstinence in patients with alcohol dependence. Addict Biol. 2015;20:513–22.

  119. 119.

    Gao J, Li Y, Zhu N, Brimijoin S, Sui N. Roles of dopaminergic innervation of nucleus accumbens shell and dorsolateral caudate-putamen in cue-induced morphine seeking after prolonged abstinence and the underlying D1- and D2-like receptor mechanisms in rats. J Psychopharmacol. 2013;27:181–91.

  120. 120.

    Madsen HB, Brown RM, Short JL, Lawrence AJ. Investigation of the neuroanatomical substrates of reward seeking following protracted abstinence in mice. J Physiol. 2012;590:2427–42.

  121. 121.

    Shalev U, Morales M, Hope B, Yap J, Shaham Y. Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology. 2001;156:98–107.

  122. 122.

    Di Ciano P, Everitt BJ. Conditioned reinforcing properties of stimuli paired with self-administered cocaine, heroin or sucrose: implications for the persistence of addictive behaviour. Neuropharmacology. 2004;47:202–13.

  123. 123.

    Theberge FR, Pickens CL, Goldart E, Fanous S, Hope BT, Liu QR, et al. Association of time-dependent changes in mu opioid receptor mRNA, but not BDNF, TrkB, or MeCP2 mRNA and protein expression in the rat nucleus accumbens with incubation of heroin craving. Psychopharmacology. 2012;224:559–71.

  124. 124.

    Theberge FR, Li X, Kambhampati S, Pickens CL, St Laurent R, Bossert JM, et al. Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving. Biol Psychiatry. 2013;73:729–37.

  125. 125.

    Doherty JM, Cooke BM, Frantz KJ. A role for the prefrontal cortex in heroin-seeking after forced abstinence by adult male rats but not adolescents. Neuropsychopharmacology. 2013;38:446–54.

  126. 126.

    Kuntz KL, Patel KM, Grigson PS, Freeman WM, Vrana KE. Heroin self-administration: II. CNS gene expression following withdrawal and cue-induced drug-seeking behavior. Pharmacol Biochem Behav. 2008;90:349–56.

  127. 127.

    Kuntz-Melcavage KL, Brucklacher RM, Grigson PS, Freeman WM, Vrana KE. Gene expression changes following extinction testing in a heroin behavioral incubation model. BMC Neurosci. 2009;10:95.

  128. 128.

    Fanous S, Goldart EM, Theberge FR, Bossert JM, Shaham Y, Hope BT. Role of orbitofrontal cortex neuronal ensembles in the expression of incubation of heroin craving. J Neurosci. 2012;32:11600–9.

  129. 129.

    Cruz FC, Koya E, Guez-Barber DH, Bossert JM, Lupica CR, Shaham Y, et al. New technologies for examining the role of neuronal ensembles in drug addiction and fear. Nat Rev Neurosci. 2013;14:743–54.

  130. 130.

    Airavaara M, Pickens CL, Stern AL, Wihbey KA, Harvey BK, Bossert JM, et al. Endogenous GDNF in ventral tegmental area and nucleus accumbens does not play a role in the incubation of heroin craving. Addict Biol. 2011;16:261–72.

  131. 131.

    Lu L, Wang X, Wu P, Xu C, Zhao M, Morales M, et al. Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving. Biol Psychiatry. 2009;66:137–45.

  132. 132.

    Blackwood CA, Hoerle R, Leary M, Schroeder J, Job MO, McCoy MT, et al. (2018). Molecular adaptations in the rat dorsal striatum and hippocampus following abstinence-induced incubation of drug seeking after escalated oxycodone self-administration. Mol Neurobiol. (in press).

  133. 133.

    Azrin NH, Holz WC. Punishment. In: Honig WK, editor.. Operant behavior: areas of research and application.. Englewood Cliffs, N.J: Prentice-Hall; 1966. p. 380–447.

  134. 134.

    Jenkins TN, Warner LH, Warden CJ. Standard apparatus for the study of animal motivation. J Comp Psychol. 1926;6:361–82.

  135. 135.

    Panlilio LV, Thorndike EB, Schindler CW. Lorazepam reinstates punishment-suppressed remifentanil self-administration in rats. Psychopharmacology. 2005;179:374–82.

  136. 136.

    Peck JA, Wercberger R, Kariyeva E, Ranaldi R. Cue-induced resumption of heroin and cocaine seeking in rats using a conflict model of abstinence and relapse. Psychopharmacology. 2013;228:651–8.

  137. 137.

    Peck JA, Galaj E, Eshak S, Newman KL, Ranaldi R. Environmental enrichment induces early heroin abstinence in an animal conflict model. Pharmacol Biochem Behav. 2015;138:20–25.

  138. 138.

    Lenoir M, Ahmed SH. Heroin-induced reinstatement is specific to compulsive heroin use and dissociable from heroin reward and sensitization. Neuropsychopharmacology. 2007;32:616–24.

  139. 139.

    Lenoir M, Cantin L, Vanhille N, Serre F, Ahmed SH. Extended heroin access increases heroin choices over a potent nondrug alternative. Neuropsychopharmacology. 2013;38:1209–20.

  140. 140.

    Ahmed SH, Lenoir M, Guillem K. Neurobiology of addiction versus drug use driven by lack of choice. Curr Opin Neurobiol. 2013;23:581–7.

  141. 141.

    Caprioli D, Venniro M, Zhang M, Bossert JM, Warren BL, Hope BT, et al. Role of dorsomedial striatum neuronal ensembles in incubation of methamphetamine craving after voluntary abstinence. J Neurosci. 2017;37:1014–27.

  142. 142.

    Venniro M, Caprioli D, Zhang M, Whitaker LR, Zhang S, Warren BL, et al. The anterior insular cortex→central amygdala glutamatergic pathway is critical to relapse after contingency management. Neuron. 2017;96:414–27.e418.

  143. 143.

    Venniro M, Zhang M, Shaham Y, Caprioli D. Incubation of methamphetamine but not heroin craving after voluntary abstinence in male and female rats. Neuropsychopharmacology. 2017;42:1126–35.

  144. 144.

    Badiani A. Substance-specific environmental influences on drug use and drug preference in animals and humans. Curr Opin Neurobiol. 2013;23:588–96.

  145. 145.

    Badiani A, Belin D, Epstein D, Calu D, Shaham Y. Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci. 2011;12:685–700.

  146. 146.

    Montanari C, Stendardo E, De Luca MT, Meringolo M, Contu L, Badiani A. Differential vulnerability to relapse into heroin versus cocaine-seeking as a function of setting. Psychopharmacology. 2015;232:2415–24.

  147. 147.

    Marchant NJ, Campbell EJ, Pelloux Y, Bossert JM, Shaham Y (2018): Context-induced relapse after extinction versus punishment: similarities and differences. Psychopharmacology (in press).

  148. 148.

    Pelloux Y, Minier-Toribio A, Hoots JK, Bossert JM, Shaham Y. Opposite effects of basolateral amygdala inactivation on context-induced relapse to cocaine seeking after extinction versus punishment. J Neurosci. 2018;38:51–59.

  149. 149.

    Willcocks AL, McNally GP. The role of medial prefrontal cortex in extinction and reinstatement of alcohol-seeking in rats. Eur J Neurosci. 2013;37:259–68.

  150. 150.

    de Guglielmo G, Kallupi M, Scuppa G, Demopulos G, Gaitanaris G, Ciccocioppo R. Pioglitazone attenuates the opioid withdrawal and vulnerability to relapse to heroin seeking in rodents. Psychopharmacology. 2017;234:223–34.

  151. 151.

    Ghitza UE, Nair SG, Golden SA, Gray SM, Uejima JL, Bossert JM, et al. Peptide YY3-36 decreases reinstatement of high-fat food seeking during dieting in a rat relapse model. J Neurosci. 2007;27:11522–32.

  152. 152.

    Rubio FJ, Quintana-Feliciano R, Warren B, Li X, Witonsky K, Soto del Valle F, et al. (2018). Prelimbic cortex is a common brain area activated during cue-induced reinstatement of cocaine and heroin seeking in a polydrug self-administration rat model. Eur J Neurosci. (accepted pending minor revisions).

  153. 153.

    Leri F, Bruneau J, Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction. 2003;98:7–22.

  154. 154.

    Magura S, Kang SY, Nwakeze PC, Demsky S. Temporal patterns of heroin and cocaine use among methadone patients. Subst Use Misuse. 1998;33:2441–67.

  155. 155.

    Leri F, Stewart J. Drug-induced reinstatement to heroin and cocaine seeking: a rodent model of relapse in poly-drug use. Exp Clin Psychopharmacol. 2001;3:297–306.

  156. 156.

    Becker JB. Sex differences in addiction. Dialog Clin Neurosci. 2016;18:395–402.

  157. 157.

    Becker JB, Chartoff E (2018). Sex differences in neural mechanisms mediating reward and addiction. Neuropsychopharmacology. (in press).

  158. 158.

    Carroll ME, Anker JJ. Sex differences and ovarian hormones in animal models of drug dependence. Horm Behav. 2010;58:44–56.

  159. 159.

    Meisch RA, Carroll ME. Oral drug self-administration: Drugs as reinforcers. In: Bozarth MA, editor. Methods of assessing the reinforcing properties of abused drugs.. New York, NY: Springer Verlag; 1987. p. 143–61.

  160. 160.

    Davis WM, Smith SG. Role of conditioned reinforcers in the initiation, maintenance and extinction of drug-seeking behavior. Pavlov J Biol Sci. 1976;11:222–36.

  161. 161.

    de Wit H, Stewart J. Drug reinstatement of heroin-reinforced responding in the rat. Psychopharmacology. 1983;79:29–31.

  162. 162.

    Buccafusco JJ, Bain JN. A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: pharmacological modification by arecoline. Neuroscience. 2007;149:487–98.

  163. 163.

    Shaham Y. Effect of stress on opioid-seeking behavior: evidence from studies with rats. Ann Behav Med. 1996;18:255–63.

  164. 164.

    Shalev U, Grimm JW, Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev. 2002;54:1–42.

  165. 165.

    Catania CA. Learning. 3rd ed. Englewood Cliffs, N.J: Prentice-Hall; 1992.

  166. 166.

    Sanger DJ, Blackman DE. Rate-dependent effects of drugs: a review of the literature. Pharmacol Biochem Behav. 1976;4:73–83.

  167. 167.

    Geller I, Kulak JT Jr, Seifter J. The effects of chlordiazepoxide and chlorpromazine on a punishment discrimination. Psychopharmacologia. 1962;3:374–85.

  168. 168.

    Wise RA, Rompre PP. Brain dopamine and reward. Annu Rev Psychol. 1989;40:191–225.

  169. 169.

    Kalivas PW, McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology. 2003;168:44–56.

  170. 170.

    Bossert JM, Marchant NJ, Calu DJ, Shaham Y. The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology. 2013;229:453–76.

  171. 171.

    Heilig M, Epstein DH, Nader MA, Shaham Y. Time to connect: bringing social context into addiction neuroscience. Nat Rev Neurosci. 2016;17:592–9.

  172. 172.

    Epstein DH, Heilig M, Shaham Y (2018). Science-based actions can help address the opioid crisis. Trends Pharmacol Sci. (in press).

  173. 173.

    Satel S, Lilienfeld SO. Addiction and the brain-disease fallacy. Front Psychiatry. 2013;4:141.

  174. 174.

    Epstein DH, Preston KL, Stewart J, Shaham Y. Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology. 2006;189:1–16.

  175. 175.

    Jasinski DR, Pevnick JS, Griffith JD. Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch Gen Psychiatry. 1978;35:501–16.

  176. 176.

    Leri F, Tremblay A, Sorge RE, Stewart J. Methadone maintenance reduces heroin- and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of poly-drug use. Neuropsychopharmacology. 2004;29:1312–20.

  177. 177.

    Sorge RE, Rajabi H, Stewart J. Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement. Neuropsychopharmacology. 2005;30:1681–92.

  178. 178.

    Bossert JM, Hoots JK, Negus SS, Blough BE, Shaham Y. Modeling opioid maintenance therapy in rats: Effects of chronic buprenorphine and the biased mu opioid receptor agonist TRV130 on relapse to oxycodone seeking. Poster abstract at Society for Neuroscience 2018 annual meeting.

  179. 179.

    Kowalczyk WJ, Phillips KA, Jobes ML, Kennedy AP, Ghitza UE, Agage DA, et al. Clonidine maintenance prolongs opioid abstinence and decouples stress from craving in daily life: a randomized controlled trial with ecological momentary assessment. Am J Psychiatry. 2015;172:760–7.

  180. 180.

    Kwako LE, Spagnolo PA, Schwandt ML, Thorsell A, George DT, Momenan R, et al. The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study. Neuropsychopharmacology. 2015;40:1053–63.

  181. 181.

    Schwandt ML, Cortes CR, Kwako LE, George DT, Momenan R, Sinha R, et al. The CRF1 antagonist verucerfont in anxious alcohol-dependent women: translation of neuroendocrine, but not of anti-craving effects. Neuropsychopharmacology. 2016;41:2818–29.

  182. 182.

    Shaham Y, de Wit H. Lost in translation: CRF1 receptor antagonists and addiction treatment. Neuropsychopharmacology. 2016;41:2795–7.

  183. 183.

    Marchant NJ, Khuc TN, Pickens CL, Bonci A, Shaham Y. Context-induced relapse to alcohol seeking after punishment in a rat model. Biol Psychiatry. 2013;73:256–62.

Download references

Acknowledgments

We would like to thank David Epstein, Sam Golden and Marco Venniro for their comments on the manuscript and Sarah Applebey, Hannah Korah, and Trinity Russell for proofreading the manuscript.

Funding: Supported by funds to the Intramural Research Program of NIDA (Y.S.) and a National Institute of General Medical Sciences Postdoctoral Research Associate Grant 1F12GM128603 (DJR).

Author information

Affiliations

  1. Behavioral Neuroscience Research Branch, IRP-NIDA-NIH, Baltimore, MD, USA

    • David J. Reiner
    • , Ida Fredriksson
    • , Olivia M. Lofaro
    • , Jennifer M. Bossert
    •  & Yavin Shaham

Authors

  1. Search for David J. Reiner in:

  2. Search for Ida Fredriksson in:

  3. Search for Olivia M. Lofaro in:

  4. Search for Jennifer M. Bossert in:

  5. Search for Yavin Shaham in:

Competing interests

The authors declare no competing interests.

Corresponding authors

Correspondence to David J. Reiner or Yavin Shaham.

Electronic supplementary material

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/s41386-018-0234-2